Retina

A novel oral therapeutic showed promising results in a Phase 2 study involving 13 subjects

How robotics and gene therapies are shaping retina research, now and in the days to come

The research findings highlighted a new therapeutic avenue in ocular and neurodegenerative disease

Investigators studied global-flash multifocal electroretinogram responses

A different approach better serves patients with diabetic retinopathy

Dr Yorston delivered the Gisbert Richard Lecture at this year's EURETINA Congress

The e-poster came in 2nd place for the August Deutman award at the EURETINA Congress

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab

Carl Awh, MD, FASRS, spoke the value of the international community of retina clinicians connecting at global meetings

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response

Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations

Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD

Prof Bodaghi praises the ingenuity at this year's EURETINA Innovation Spotlight (EIS)

Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD

The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here

Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care

Additional previous surgeries and the duration of the SO tamponade had little or no impact

Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial

New research and EURETINA highlights from the director of the "underdog" eye clinic

How retinal imaging can provide clinicians a deeper understanding of myopia

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies